-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENERON PHARMACEUTICALS - SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR LIBTAYO DOSING UNDER REVIEW IN U.S., DECISION EXPECTED MARCH 2027

Reuters·11/17/2026 12:02:34